FDA Inspection 1014489 — Holy Cross of Silver Spring Blood Bank
The FDA completed an inspection of Holy Cross of Silver Spring Blood Bank on May 25, 2017 in Silver Spring, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 25, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Silver Spring, MD (United States)